Western Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
VCM
VPM
Western Wealth Management's VRTX Position: Q1 2026 in Review
Western Wealth Management increased its Vertex Pharmaceuticals (VRTX) stake by 160% in Q1 2026, buying an estimated $468K and bringing the position to 1,631 shares worth $728K. The position accounts for 0.03% of the portfolio, ranked #541.
Western Wealth Management first reported a position in VRTX in Q1 2022 and has held it in 11 quarters since. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.
- Western Wealth Management held 1,631 shares of Vertex Pharmaceuticals worth $728K as of Q1 2026.
- Western Wealth Management bought 1,003 Vertex Pharmaceuticals shares in Q1 2026, an estimated $468K.
- Vertex Pharmaceuticals made up 0.03% of Western Wealth Management's portfolio in Q1 2026, its #541 holding.
- Western Wealth Management first reported a position in Vertex Pharmaceuticals in Q1 2022 and has held it in 11 quarters since.
- 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.
Based on Western Wealth Management's 13F filing for Q1 2026, filed 19 May 2026.